ketanserin has been researched along with Apoplexy in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Stroke was significantly delayed in rats with high BRS than those with low BRS (time to 50% death was 1." | 1.34 | Arterial baroreflex: a novel target for preventing stroke in rat hypertension. ( Chen, H; Liu, AJ; Liu, JG; Ma, XJ; Shen, FM; Su, DF, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, AJ | 1 |
Ma, XJ | 1 |
Shen, FM | 1 |
Liu, JG | 1 |
Chen, H | 1 |
Su, DF | 1 |
1 other study available for ketanserin and Apoplexy
Article | Year |
---|---|
Arterial baroreflex: a novel target for preventing stroke in rat hypertension.
Topics: Animals; Baroreflex; Blood Pressure; Drug Delivery Systems; Female; Hypertension; Ketanserin; Male; | 2007 |